Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ESMO Congress 2025
ACS Clinical Congress 2025
2025 ASCO Quality Care Symposium
2025 ASTRO Annual Meeting
2025 Debates and Didactics in Hematology and Oncology
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2017 ASCO Annual Meeting,2017 ASCO Annual Meeting
«
1
»
Advertisement
Advertisement
Nov
17
Today In Oncology
Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated NSCLC After Tyrosine Kinase Inhibitor Failure
Could a Liquid Biopsy Lead to Earlier Diagnoses for Numerous Cancer Types
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
FDA Approves Ziftomenib for NPM1-Positive AML
Pancreatic Cancer Mild Duct Dilation May Serve as Early Indicator in High-Risk Patients
View More
Advertisement
